Arrow Mark Colorado Holdings LLC Instil Bio, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.37 $930,455 - $1.47 Million	-200,098 Reduced 7.71%	2,393,683 $11.6 Million
Q2 2022 Aug 15, 2022	BUY	$4.21 - $11.15 $5.31 Million - $14.1 Million	1,260,554 Added 94.55%	2,593,781 $12 Million
Q1 2022 May 16, 2022	BUY	$8.48 - $18.1 $367,421 - $784,236	43,328 Added 3.36%	1,333,227 $14.3 Million
Q4 2021 Feb 14, 2022	BUY	$15.37 - $22.5 $363,162 - $531,630	23,628 Added 1.87%	1,289,899 $22.1 Million
Q3 2021 Nov 15, 2021	BUY	$15.05 - $23.28 $1.92 Million - $2.97 Million	127,566 Added 11.2%	1,266,271 $22.6 Million
Q2 2021 Aug 16, 2021	BUY	$15.31 - $24.63 $979,916 - $1.58 Million	64,005 Added 5.96%	1,138,705 $12.8 Million
Q1 2021 May 17, 2021	BUY	$24.23 - $27.06 $26 Million - $29.1 Million	1,074,700 New	1,074,700 $27 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $3.23B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.